Skip to main content

Episode 1: Navigating COVID-19 Breakthrough Infections featuring Dr. Huapaya

Discovering Hope in Science

In this episode, we sit down with Dr. Julio Huapaya, a Senior Critical Care Fellow in the Clinical Center's Critical Care Medicine Department, to discuss his published journal article. We review the importance of his findings and implications to the public health. In this study, researchers evaluated patients who had been vaccinated against SARS-CoV-2 and had breakthrough infections and compared them to unvaccinated patients infected with SARS-CoV-2. The study showed that vaccinations may help limit the progression of inflammatory responses associated with disease severity.

Listen and Subscribe to Discovering Hope in Science


On this page:

Featured Speaker: Dr. Julio Huapaya  |  Show Notes  |  Episode Transcript


portrait of Dr. Julio Huapaya

Dr. Julio Huapaya received his Doctor of Medicine degree from Universidad Peruana Cayetano Heredia in Peru. He completed residency training in Internal Medicine at Georgetown University Hospital and Fellowship in Pulmonary Medicine at the University of Maryland. He joined the NIH Critical Care Program because he sought a research-oriented program with an emphasis on clinical training. Dr. Huapaya is passionate about interstitial lung disease (ILD) and is working in Dr. Anthony Suffredini's lab where they are studying the immune response of patients who have been infected with SARS-COV-2.


Show Notes

COVID-19 cells

Episode Transcript

Read the full transcript ▾